Archives of Neuroscience

Published by: Kowsar

Topical Lidocaine for Localized Neuropathic Pain

Simona Lattanzi 1 , * and Leandro Provinciali 1
Authors Information
1 Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy
Article information
  • Archives of Neuroscience: January 01, 2016, 3 (1); e28698
  • Published Online: January 9, 2016
  • Article Type: Discussion
  • Received: March 14, 2015
  • Accepted: June 15, 2015
  • DOI: 10.5812/archneurosci.28698

To Cite: Lattanzi S, Provinciali L. Topical Lidocaine for Localized Neuropathic Pain, Arch Neurosci. 2016 ; 3(1):e28698. doi: 10.5812/archneurosci.28698.

Copyright © 2016, Tehran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Arguments
3. Conclusions
Footnote
References
  • 1. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008; 70(18): 1630-5[DOI][PubMed]
  • 2. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007; 68(15): 1178-82[DOI][PubMed]
  • 3. O'Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics. 2009; 27(2): 95-112[DOI][PubMed]
  • 4. Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010; 149(2): 338-44[DOI][PubMed]
  • 5. McDermott AM, Toelle TR, Rowbotham DJ, Schaefer CP, Dukes EM. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain. 2006; 10(2): 127-35[DOI][PubMed]
  • 6. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010; 9(8): 807-19[DOI][PubMed]
  • 7. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015; 14(2): 162-73[DOI][PubMed]
  • 8. Mick G, Baron R, Finnerup NB, Hans G, Kern KU, Brett B, et al. What is localized neuropathic pain? A first proposal to characterize and define a widely used term. Pain Manag. 2012; 2(1): 71-7[DOI][PubMed]
  • 9. Jorge LL, Feres CC, Teles VE. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res. 2011; 4: 11-24[DOI][PubMed]
  • 10. Mick G, Correa-Illanes G. Topical pain management with the 5% lidocaine medicated plaster--a review. Curr Med Res Opin. 2012; 28(6): 937-51[DOI][PubMed]
  • 11. Versatis 5% Medicated Plaster . 2014;
  • 12. Madsen CS, Johnsen B, Fuglsang-Frederiksen A, Jensen TS, Finnerup NB. Differential effects of a 5% lidocaine medicated patch in peripheral nerve injury. Muscle Nerve. 2013; 48(2): 265-71[DOI][PubMed]
  • 13. Wall PD. Neuropathic pain and injured nerve: central mechanisms. Br Med Bull. 1991; 47(3): 631-43[PubMed]
  • 14. Provinciali L, Lattanzi S, Chiarlone R, Fogliardi A, Intelligente F, Irace C, et al. [Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain]. Minerva Med. 2014; 105(6): 515-27[PubMed]
  • 15. Wolf MS, Curtis LM, Waite K, Bailey SC, Hedlund LA, Davis TC, et al. Helping patients simplify and safely use complex prescription regimens. Arch Intern Med. 2011; 171(4): 300-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments